Gestational diabetes mellitus and macrosomia: A literature review

Annals of Nutrition and Metabolism

Volumn 66, Issue , 2015, Pages 14-20

  Kc, Kamana ^a   Shakya, Sumisti ^b   Zhang, Hua ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Epigenetics; Gestational diabetes mellitus; Hyperglycemia; Large for gestational age; Macrosomia; Obesity; Pregnancy

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; HUMAN PLACENTA LACTOGEN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA; GLUCOSE BLOOD LEVEL; INSULIN;

ADIPOSE TISSUE; ADVERSE OUTCOME; BODY FAT; BRACHIAL PLEXUS INJURY; CESAREAN SECTION; CHILDHOOD OBESITY; CLAVICLE FRACTURE; CONGENITAL MALFORMATION; DNA METHYLATION; EPIGENETICS; ERB PALSY; FETOPLACENTAL UNIT; FETUS CIRCULATION; FETUS LUNG MATURATION; GENE EXPRESSION; GENITAL INJURY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HISTONE MODIFICATION; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LABOR INDUCTION; LARGE FOR GESTATIONAL AGE; MACROSOMIA; MATERNAL DIABETES MELLITUS; MATERNAL OBESITY; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; NEWBORN DISEASE; NEWBORN JAUNDICE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PLACENTA CIRCULATION; POSTPARTUM HEMORRHAGE; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURITY; PRIORITY JOURNAL; REVIEW; SHOULDER DYSTOCIA; UTERINE ATONY; ANALYSIS; COMPLICATION; DYSTOCIA; EMBRYOLOGY; FEMALE; FETAL MACROSOMIA; FETOMATERNAL TRANSFUSION; GENETIC EPIGENESIS; GENETICS; METABOLISM; NEWBORN; OVERWEIGHT; PANCREAS; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; SECRETION (PROCESS); SHOULDER;

ADIPOSE TISSUE; BLOOD GLUCOSE; CESAREAN SECTION; DIABETES, GESTATIONAL; DYSTOCIA; EPIGENESIS, GENETIC; FEMALE; FETAL MACROSOMIA; HUMANS; INFANT, NEWBORN; INSULIN; INSULIN RESISTANCE; MATERNAL-FETAL EXCHANGE; METABOLIC SYNDROME X; OBESITY; OVERWEIGHT; PANCREAS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SHOULDER;

EID: 84930606826     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000371628     Document Type: Review

References (49)

1. Ehrenberg HM, Mercer BM, Catalano PM: The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol 2004; 191: 964-968.
2. Yogev Y, Langer O: Pregnancy outcome in obese and morbidly obese gestational diabetic women. Eur J Obstet Gynecol Reprod Biol 2008; 137: 21-26.
3. Jovanovic-Peterson L, Peterson CM, Reed GF, Metzger BE, Mills JL, Knopp RH, et al: Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development-Diabetes in Early Pregnancy Study. Am J Obstet Gynecol 1991; 164: 103-111.
4. McFarland MB, Trylovich CG, Langer O: Anthropometric differences in macrosomic infants of diabetic and nondiabetic mothers. J Matern Fetal Med 1998; 7: 292-295.
5. Athukorala C, Crowther CA, Willson K: Women with gestational diabetes mellitus in the ACHOIS trial: risk factors for shoulder dystocia. Aust NZ J Obstet Gynaecol 2007; 47: 37-41.
6. Hunter DJ, Burrows RF, Mohide PT, Whyte RK: Influence of maternal insulin-dependent diabetes mellitus on neonatal morbidity. CMAJ 1993; 149: 47-52.
7. Simmons D: Interrelation between umbilical cord serum sex hormones, sex hormonebinding globulin, insulin-like growth factor I, and insulin in neonates from normal pregnancies and pregnancies complicated by diabetes. J Clin Endocrinol Metab 1995; 80: 2217-2221.
8. Ryan EA, Enns L: Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab 1998; 67: 341-347.
9. Ahmed SA, Shalayel MH: Role of cortisol in the deterioration of glucose tolerance in Sudanese pregnant women. East Afr Med J 1999; 76: 465-467.
10. Buchanan TA, Xiang AH: Gestational diabetes mellitus. J Clin Invest 2005; 115: 485-491.
11. Catalano PM: Obesity, insulin resistance, and pregnancy outcome. Reproduction 2010; 140: 365-371.
12. Briana DD, Malamitsi-Puchner A: Reviews: adipocytokines in normal and complicated pregnancies. Reprod Sci 2009; 16: 921-937.
13. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM: Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 1994; 91: 4854-4858.
14. Hotamisligil GS, Peraldi P, Budavari A, et al: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-? and obesity-induced insulin resistance. Science 1996; 271: 665-668.
15. Al-Noaemi M, Shalayel MHF: Adiponectin. Sudan J Med Sci 2009; 4: 297-305.
16. Lazer S, Biale Y, Mazor M et al: Complications associated with the macrosomic fetus. J Reprod Med 1986;31:501-505.
17. Haji-Ebrahim-Tehrani F, Kazemi H, Kordi M: Prevalence and outcome of the macrosomic infants. Acta Med Iranica 2007; 45: 505-509.
18. McFarland LV, Raskin M, Daling JR, Benedetti TJ: Erb/Duchenne's palsy: a consequence of fetal macrosomia and method of delivery. Obstet Gynecol 1986; 68: 784-788.
19. Pettitt DJ, Nelson RG, Saad MF, Bennett PH, Knowler WC: Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care 1993; 16: 310-314.
20. Crume TL, Ogden L, West NA, et al: Association of exposure to diabetes in utero with adiposity and fat distribution in a multiethnic population of youth: the Exploring Perinatal Outcomes among Children (EPOCH) study. Diabetologia 2011; 54: 87-92.
21. Crume TL, Ogden L, Daniels S, Hamman RF, Norris JM, Dabelea D: The impact of in utero exposure to diabetes on childhood body mass index growth trajectories: the EPOCH study. J Pediatr 2011; 158: 941-946.
22. Barker DJ, Eriksson JG, Forsén T, Osmond C: Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 2002; 31: 1235-1239.
23. Gillman MW: Developmental origins of health and disease. N Engl J Med 2005; 353: 1848-1850.
24. Wolffe AP, Guschin D: Review: chromatin structural features and targets that regulate transcription. J Struct Biol 2000; 129: 102-122.
25. Handel AE, Ebers GC, Ramagopalan SV: Epigenetics: molecular mechanisms and implications for disease. Trends Mol Med 2010; 16: 7-16.
26. Bollati V, Baccarelli A: Environmental epigenetics. Heredity 2010; 105: 105-112.
27. Smallwood SA, Kelsey G: De novo DNA methylation: a germ cell perspective. Trends Genet 2012;28:33-42.
28. El Hajj N, Pliushch G, Schneider E, Dittrich M, Müller T, Korenkov M, Aretz M, Zechner U, Lehnen H, Haaf T: Metabolic programming of MEST DNA methylation by intrauterine exposure to gestational diabetes mellitus. Diabetes 2013;62:1320-1328.
29. Moore TR: Fetal exposure to gestational diabetes contributes to subsequent adult metabolic syndrome. Am J Obstet Gynecol 2010;202:643-649.
30. Ding GL, Wang FF, Shu J, et al: Transgenerational glucose intolerance with Igf2/H19 epigenetic alterations in mouse islet induced by intrauterine hyperglycemia. Diabetes 2012; 61: 1133-1142.
31. Bouchard L, Hivert M-F, Guay S-P, et al: Placental adiponectin gene DNA methylation levels are associated with mothers' blood glucose concentration. Diabetes 2012;61: 1272-1280.
32. Bouchard L, Thibault S, Guay SP, et al: Leptin gene epigenetic adaptation to impaired glucose metabolism during pregnancy. Diabetes Care 2010;33:2436-2441.
33. Uzelac PS, Li X, Lin J, et al: Dysregulation of leptin and testosterone production and their receptor expression in the human placenta with gestational diabetes mellitus. Placenta 2010;31:581-588.
34. Houde A-A, Hivert M-F, Bouchard L: Fetal epigenetic programming of adipokines. Adipocyte 2013;2:41-46.
35. Simmons D: Diabetes and obesity in pregnancy. Best Pract Res Clin Obstet Gynaecol 2011; 25: 25-36.
36. Chu SY, Callaghan WM, Kim SY, et al: Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care 2007; 30: 2070-2076.
37. Metzger BE, Lowe LP, Dyer AR, et al: The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: associations of higher levels of maternal glucose and BMI with macrosomia: an example of diabesity. ADA 70th Scientific Session, 2010. Abstract No. 154-OR. http://professional.diabetes.org/Abstracts-Display.aspx?TYP=1&CID=79099.
38. Ryan EA: Diagnosing gestational diabetes. Diabetologia 2011; 54: 480-486.
39. Ricart W, Lopez J, Mozas J, et al: Body mass index has a greater impact on pregnancy outcomes than gestational hyperglycaemia. Diabetologia 2005; 48: 1736-1742.
40. Conway DL, Langer O: Elective delivery of infants with macrosomia in diabetic women: reduce shoulder dystocia versus increase cesarean deliveries. Am J Obstet Gynecol 1998; 178: 922-925.
41. American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics: ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol 2001; 98: 525-538.
42. Sanchez-Ramos L, Bernstein S, Kaunitz AM: Expectant management versus labor induction for suspected fetal macrosomia: a systematic review. Obstet Gynecol 2002; 100: 997-1002.
43. Ott WJ: The diagnosis of altered fetal growth. Obstet Gynecol Clin North Am 1988; 15: 237-263.
44. Cheng YW, Sparks TN, Laros RK, Nicholson JM, Caughey AB: Impending macrosomia: will induction of labour modify the risk of caesarean delivery? BJOG 2012; 119: 402-409.
45. Friesen CD, Miller AM, Rayburn WF: Influence of spontaneous or induced labor on delivering the macrosomic fetus. Am J Perinatol 1995; 12: 63-66.
46. Combs CA, Singh NB, Khoury JC: Elective induction versus spontaneous labor after sonographic diagnosis of fetal macrosomia. Obstet Gynecol 1993; 81: 492-496.
47. Horrigan TJ: Physicians who induced labor for fetal macrosomia do not reduce cesarean delivery rates. J Perinatol 2001; 21: 91-96.
48. Hall MH: Guessing the weight of the baby. Br J Obstet Gynaecol 1996; 103: 734-736.
49. Chauhan SP, Grobman WA, Gherman RA, et al: Suspicion and treatment of the macrosomic fetus: a review. Am J Obstet Gynecol 2005; 193: 332-346.